GE HealthCare and Masimo have signed an agreement for the integration of Masimo Signal Extraction Technology (SET) pulse oximetry with the Portrait Mobile wireless and wearable patient monitoring solution.
Leveraging the latest cloud-native technology, GE’s Portrait Mobile is developed as an Internet of Medical Things (IoMT) platform for delivering an end-to-end experience for wearable continuous monitoring.
Through Masimo SET integration, clinicians can utilise Masimo’s Measure-through Motion and Low Perfusion oxygen saturation (SpO₂) measurement technology for noninvasively identifying and continuously monitoring changes in patient status.
The agreement comes after Portrait Mobile received 510(k) clearance from the US Food and Drug Administration (FDA) in August this year.
The collaboration allows for continuous real-time monitoring of patients’ vital signs, providing a personalised view.
It will also allow patients to remain mobile during crucial recovery phases, particularly following surgery or discharge from the intensive care unit.
Access the most comprehensive Company Profiles
on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Company Profile – free
sample
Thank you!
Your download email will arrive shortly
We are confident about the
unique
quality of our Company Profiles. However, we want you to make the most
beneficial
decision for your business, so we offer a free sample that you can download by
submitting the below form
By GlobalData
GE HealthCare Monitoring Solutions general manager Neal Sandy said: “Portrait Mobile is built as an open platform with the capability to be compatible with other technologies.
“The ability to integrate Masimo’s innovative SET pulse oximetry in a wearable sensor demonstrates the flexibility and scalability of our new platform while leveraging Masimo’s measurement expertise.”
Last month, GE HealthCare received 510(k) clearance from the FDA for its new image-guided system, Allia IGS Pulse.
The new system is based on the Allia platform, intended for image-guided therapies and aimed at improving workflow to diagnose and treat cardiovascular diseases in interventional cardiology.
